Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study
Authors:
- Kang OuyangKOKang Ouyang
- Jagadish HiremathJHJagadish Hiremath
- Basavaraj BinjawadagiBBBasavaraj Binjawadagi
- Duan-Liang ShyuDSDuan-Liang Shyu
- Santosh DhakalSDSantosh Dhakal
- Jesus ArcosJAJesus Arcos
- Rose SchleappiRSRose Schleappi
- Lynette HolmanLHLynette Holman
- Michael RoofMRMichael Roof
- Jordi B. TorrellesJTJordi B. Torrelles
- Gourapura J. RenukaradhyaGourapura J. Renukaradhya
Open Access
- 17 March 2016
- journal article
- research article
- Published by Springer Nature in Veterinary Research
- Vol. 47 (1) , 1-11
Abstract
Porcine reproductive and respiratory syndrome (PRRS) is caused by PRRS virus (PRRSV), which infects primarily the respiratory tract of pigs. Thus intranasal (IN) delivery of a potent vaccine-adjuvant formulation is promising. In this study, PRRS-MLV (VR2332) was coadministered ± an adjuvant Mycobacterium vaccae whole cell lysate or CpG ODN through intramuscular (IM) or IN route as a mist, and challenged with a heterologous PRRSV 1-4-4 IN at 42 days post-vaccination (dpv). At 14 and 26 dpv, vaccine viral RNA copies were one log greater in the plasma of PRRS-MLV IM compared to IN vaccinated pigs, and the infectious replicating vaccine virus was detected only in the IM group. In PRRS-MLV ± adjuvant IM vaccinated pigs, reduced viral RNA load and absence of the replicating challenged virus was observed at 7, 10 and 14 days post-challenge (dpc). At 14 dpc, in BAL fluid ≥5 log viral RNA copies were detected in all the pig groups, but the replicating challenged virus was undetectable only in IM groups. Immunologically, virus neutralizing antibody titers in the plasma of IM (but not IN) vaccine groups was ≥8 against the vaccine and challenged viruses. At 26 dpv, PRRS-MLV IM (without adjuvant) received pigs had significantly increased population of CD4 and CD8 T cells in PBMC. At 14 dpc, relatively increased population of IFN-γ+ total lymphocytes, NK, CD4, CD8 and γδ T cells were observed in the MLV-IM group. In conclusion, PRRS-MLV IM vaccination induced the virus specific T cell response in pigs, but still it is required to improve its cross-protective efficacy.Keywords
Funding Information
- USDA-AFRI (2012-67015-21823)
- USDA-NIFA PRRSCAP2 (2008-55620-19132)
This publication has 49 references indexed in Scilit:
- Phenotypic maturation of porcine NK- and T-cell subsetsDevelopmental & Comparative Immunology, 2013
- Immunization of pigs with a type 2 modified live PRRSV vaccine prevents the development of a deadly long lasting hyperpyrexia in a challenge study with highly pathogenic PRRSV JX143Vaccine, 2013
- CpG DNA as a vaccine adjuvantExpert Review of Vaccines, 2011
- Phylogeny-Based Evolutionary, Demographical, and Geographical Dissection of North American Type 2 Porcine Reproductive and Respiratory Syndrome VirusesJournal of Virology, 2010
- Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in miceJournal of Clinical Investigation, 2010
- Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunityProceedings of the National Academy of Sciences, 2009
- Protection against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection through Passive Transfer of PRRSV-Neutralizing Antibodies Is Dose DependentClinical and Vaccine Immunology, 2007
- Complete genome analysis of RFLP 184 isolates of porcine reproductive and respiratory syndrome virusVirus Research, 2006
- Molecular epidemiology of porcine reproductive and respiratory syndrome virus (PRRSV) in QuébecVirus Research, 2003
- Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell lineArchives of Virology, 1993